Viyash Scientific Limited announced the impending resignations of two Non-Executive Directors: Dr. Fabian Kausche and Mr. Gregory Andrews. Both individuals cited personal reasons and other commitments as the basis for their decisions. Their resignations are formally set to take effect on March 30, 2026. The company has provided the necessary regulatory disclosures and enclosed their formal resignation letters as annexures to the filing dated March 30, 2025.
Board Changes Announced by Viyash Scientific
Viyash Scientific Limited (formerly Sequent Scientific Limited) has formally informed the stock exchanges regarding changes in its Board of Directors. The company confirmed that two key members, serving in non-executive capacities, have communicated their intention to step down from their roles.
Details of Director Resignations
The two directors slated for resignation are:
- Dr. Fabian Kausche (DIN: 08976500): Resigning due to personal reasons and commitments.
- Mr. Gregory Andrews (DIN: 08904518): Also resigning due to personal reasons and other commitments.
Crucially, both resignations are slated to be effective in the future, on March 30, 2026. The official notice detailing the event was issued on March 30, 2025, ensuring compliance with disclosure timelines.
Regulatory Compliance and Documentation
In accordance with regulatory requirements, Viyash Scientific submitted detailed information regarding the cessation of directorships as mandated under Schedule III. The resignations were voluntary, and the company confirmed that the full letters of resignation from both Dr. Kausche and Mr. Andrews have been enclosed as Annexure B and Annexure C, respectively. The company has requested prompt acknowledgment and completion of all necessary formalities.
Source: BSE
